EFFIMIA 0,250 mg/0,035mg, Compresse clinical trials

A multicentre, prospective, open-label, non-comparative study to evaluate menstrual bleeding typology, tolerability, and compliance during a monophasic hormonal contraceptive treatment with norgestimate + ethinylestradiol in Italy.”

This study looks at how a specific birth control pill (Effimia) affects periods, side effects, and if women take it as prescribed. It's for women using the pill for contraception in Italy.